Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 27-12-2024 |
Asset Class: |
Benchmark: BSE Healthcare TRI |
TER: 2.36% As on (28-02-2025) |
Status: Open Ended Schemes |
Minimum Investment: 0.0 |
Minimum Topup: 0.0 |
Total Assets: 283 Cr As on 28-02-2025(Source:AMFI) |
Turn over: - |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Standard Deviation | - |
Sharpe Ratio | - |
Alpha | - |
Beta | - |
Yield to Maturity | - |
Average Maturity | - |
Small Cap
27.44%
Others
7.75%
Large Cap
38.79%
Mid Cap
26.02%